{"id":"azd4017","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Hypotension"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL2153191","moleculeType":"Small molecule","molecularWeight":"419.59"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting NHE1, AZD4017 reduces the influx of sodium ions into cardiac myocytes, which can help to prevent cardiac arrhythmias and reduce the risk of stroke in patients with atrial fibrillation.","oneSentence":"AZD4017 is a small molecule inhibitor of the sodium-hydrogen exchanger 1 (NHE1).","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:30:18.998Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT02017444","phase":"PHASE2","title":"Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.","status":"COMPLETED","sponsor":"University of Birmingham","startDate":"2014-04-25","conditions":"Idiopathic Intracranial Hypertension","enrollment":31},{"nctId":"NCT03111810","phase":"PHASE2","title":"Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2017-05-25","conditions":"Iatrogenic Cushing's Disease","enrollment":32},{"nctId":"NCT03313297","phase":"PHASE2","title":"Glucocorticoids and Skin Healing in Diabetes (GC-SHealD)","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2018-04-10","conditions":"Diabetes Mellitus, Type 2","enrollment":28},{"nctId":"NCT01173471","phase":"PHASE2","title":"A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-12","conditions":"Raised Intraocular Pressure","enrollment":50},{"nctId":"NCT01096004","phase":"PHASE1","title":"Study to Evaluate Methods That Assess the Effect of AZD4017 in Adipose Tissue","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-03","conditions":"Obesity","enrollment":15},{"nctId":"NCT00841048","phase":"PHASE1","title":"Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-02","conditions":"Diabetes Mellitus Type 2","enrollment":107},{"nctId":"NCT00799747","phase":"PHASE1","title":"Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-12","conditions":"Healthy","enrollment":56},{"nctId":"NCT00791752","phase":"PHASE1","title":"Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-11","conditions":"Healthy","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["11b-Hydroxysteroid dehydrogenase type 1 inhibitor"],"phase":"phase_2","status":"active","brandName":"AZD4017","genericName":"AZD4017","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AZD4017 is a small molecule inhibitor of the sodium-hydrogen exchanger 1 (NHE1). Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":2,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}